Research interests
- CRISPR-Cas9 technologies and genome editing
- Blood group antigen discovery
- Rare blood cell phenotypes
BaHSic — Blood group Antigens, Hematopoiesis and Sickle cell disease
Hematopoiesis & Translational Research: blood cell biology, multi-omic approaches, and translational studies.
Contact (+33) 1 81 72 43 14 sara.bencheikh@inserm.fr
Location Hôpital Necker – Enfants Malades 149 rue de Sèvres 75015 ParisResearch engineer
Inserm U1134 – BAHSic Lab
Dr Romain Duval is a researcher specializing in CRISPR-Cas9 technologies and genome editing. His work focuses on the development and application of gene-editing approaches to facilitate the discovery of new blood group antigens and the production of blood cells with rare phenotypes. In parallel, he also teaches at Université de Paris, where he delivers courses on genome engineering and contributes to the training of undergraduate, master’s, and doctoral students.